Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—
About
ALIVE Israel Healthtech Fund is a mid-to-late-stage healthtech investment fund that operates through a strategic partnership model to support the clinical and commercial expansion of its portfolio companies. The fund focuses on Medtech, Digital Health, and Bio Convergence, with a strong emphasis on the U.S. market and global outreach. By collaborating with hospital chains, HMOs, financial institutions, venture capital firms, and crossover funds, the fund facilitates regulatory progress, business plan execution, and strategic growth for its portfolio companies.
Portfolio
No portfolio companies in this dataset yet.
Investor Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is ALIVE Israel Healthtech Fund's primary investment focus?
- ALIVE Israel Healthtech Fund is a mid-to-late-stage healthtech investment fund, focusing on Medtech, Digital Health, and Bio Convergence, with a strong emphasis on the U.S. market and global outreach.
- When was ALIVE Israel Healthtech Fund founded?
- ALIVE Israel Healthtech Fund was founded in 2020.
- Which notable companies has ALIVE Israel Healthtech Fund invested in recently?
- ALIVE Israel Healthtech Fund recently invested $55 million in Navina in March 2025 and $105 million in Magenta Medical in July 2024.
- What are some significant exits for ALIVE Israel Healthtech Fund's portfolio companies?
- According to startupim data, Innovalve Bio Medical was acquired for $300 million by Edwards Lifesciences in July 2024. Cynerio was acquired for $180 million by Axonius in July 2025.
- Which sectors does ALIVE Israel Healthtech Fund concentrate its investments in?
- ALIVE Israel Healthtech Fund primarily concentrates its investments in Health Tech & Life Sciences, with a smaller presence in Cyber Security.
- Has ALIVE Israel Healthtech Fund led investment rounds for any of its portfolio companies?
- Yes, ALIVE Israel Healthtech Fund has led investment rounds for companies such as Vessi Medical in February 2024 and Navina in October 2022.
- What is the target size for ALIVE Israel Healthtech Fund's new growth fund?
- ALIVE Israel Healthtech Fund's new growth fund has a total target size of approximately $200 million, as reported in November 2025.
- Who are the founders of ALIVE Israel Healthtech Fund?
- The founders of ALIVE Israel Healthtech Fund are Ari Shamiss, Rafael Beyar, Michel Habib, and Dudi Klein.